Background: Chronic disabling disease is present in nearly 90% of emergency medical admissions. We have examined its impact on outcomes and costs in one institution, using a database of episodes collected prospectively over 12 years. Methods: All emergency admissions (66 933 episodes; 36 271 patients) to St James' Hospital over a 12-year period (2002-13) were evaluated in relation to 30-day in-hospital mortality, length of stay (LOS) and hospital costs. Predictor variables (identified univariately) were entered into a multi-variable logistic regression model to predict 30-day in-hospital mortality. The data were also modelled as count data (absolute LOS, total cost) using zero-truncated Poisson regression. Results: Acute illness severity was the best independent predictor of mortality; chronic disabling disease was an independent predictor (P < 0.001) for patients with 4+ disabling conditions.
Introduction
Health trends suggest that while life expectancy has increased by 4.0 and 2.6 years for males and females, respectively, over the last four decades ) the time spent with a diagnosed chronic 'disabling' condition has increased by 9.2 and 9.4 years for males and females, respectively, over the same time period. 1 These findings were based on an operational definition of a 'chronic disabling condition' as proposed by the US Department of Health and Human Services. 2 In this context, disabling disease or disability broadly refers to an impairment of an individual's ability to function during routine daily tasks, for example cardiac failure or respiratory impairment. Therefore, although quantity of life has increased owing to improved living standards, prevention programmes and medical innovation, full quality of life during these extended years cannot be assumed.
and length of stay (LOS). 4 Between 2002 and 2013 with 66 933 episodes in patients admitted as a medical emergency, who completed the hospital episode or suffered an in-hospital death by Day 30, only 11 .3% of such episodes had no disabling disease code. The episode frequency of 1, 2, 3 or 4+ disabling codes was 24.7%, 29.2%, 21.0% and 13.8%, respectively; clearly with such occurrence there is every justification for focusing on these diagnoses as drivers of healthcare costs and factors in resource utilization.
Chronic disabling disease can be expected to be a driver for demand in healthcare services; there is of course increasing emphasis to identify service effectiveness 5, 6 and achieve greater healthcare cost-efficiency. 7 In our previous article, we were of the view that chronic disabling disease would be strongly associated with age and costs. The purpose of this work was to examine the presence of chronic disabling disease, from a database of unselected emergency medical patients admitted over a 12-year period, in terms of outcomes (30-day in-hospital mortality and LOS) and hospital total costs, when adjusted for other predictor variables, including acute illness severity, age groupings and other comorbidities.
Methods Background
St James's Hospital (SJH) serves as a secondary care centre for emergency admissions from its local Dublin catchment area of 270 000 adults. All emergency medical admissions are referred to one of nine teams operating a 1:9 24-hr on-call roster. The 'on-call' system is covered by a 'physician of the day' with a post-call review round. Emergency medical patients are admitted from the Emergency Department to an Acute Medical Assessment Unit (AMAU) opened in 2003, the operation and outcome of which have been described elsewhere.
8,9

Data collection
We employed an anonymous patient database assembling core information about each clinical episode from elements contained on the patient administration system, the national hospital in-patient enquiry (HIPE) scheme, the patient electronic record, the emergency room and laboratory systems. HIPE is a national database of coded discharge summaries from acute public hospitals in Ireland. 10, 11 Ireland used the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) for both diagnosis and procedure coding from 1990 to 2005 and ICD-10-CM since then.
Data held on the database include the unique hospital number, admitting consultant, date of birth, gender, area of residence, principal and up to nine additional secondary diagnoses and procedures, and admission and discharge dates. Additional information cross-linked and automatically uploaded to the database includes physiological, haematological and biochemical parameters. Data were related to all emergency general medical patients admitted to SJH in the 12 years between 2002 and 2013.
Approximately 9.9% of our patients stay >30 days with a median LOS of 54.8 days (interquartile ranges (IQR) 38.8, 97.2). Consequently, the LOS data represent a highly skewed distribution. Although the clinical episode is complete for the majority by Day 30, some patients remain for social reasons related to the lack of long-term care facilities. We have therefore chosen a truncated endpoint (at the 30-day endpoint) for analysis to avoid these additional confounders.
Disability and disabling scores
Discharge codes were interrogated to construct a 'disabling score'. To devise the score, we searched ICD9 codes (back-mapping ICD10 codes to ICD9 as appropriate as Stata routines support ICD9 and not ICD10 'calls') matching 'chronic disabling' codes based on the definition proposed by the US Department of Health and Human Services for a 'chronic disabling condition'. 2 The codes were grouped by system, as presented in Table 1 12, 13 and an FEV1/FVC ratio <50% was considered to represent a level of respiratory function sufficient to be classified as disabling (included in Group 2). Thereafter, we summed the scores from each disabling category (with minimum and maximum scores 0 and 8, respectively) for each clinical episode, as described. 4 Zero score means that none of the defined 'disability' codes was present. For each episode, there could be only one point within any system. Therefore a code of 1, 2, 3 or 4+ meant one, two, three and four or more codes, from different organ systems, as previously defined. Common disabling disease codes would include entities, such as cardiac (myocardial ischaemia, hypertension and atrial fibrillation), cerebrovascular (cerebrovascular accident, ischaemia or occlusion), gastrointestinal (gastritis, duodenitis, haemorrhage, regional enteritis and ulcerative colitis), kidney (kidney injury/insufficiency and urinary tract infection), gallbladder (cholelithiasis), liver (cirrhosis and alcohol-related diagnoses), infective (sepsis) and diabetes related.
Adjustors for multi-variable model
We tested known predictor variables for the multivariable model. The Charlson co-morbidity index provides an evaluation of co-morbidity, 14 defined as the presence of one or more additional disorders (or diseases) co-occurring with a primary disease or disorder. The Charlson co-morbidity index predicts the 10-year mortality outcomes for patients who may have a range of co-morbidity conditions, such as heart disease, AIDS or cancer (a total of 22 conditions). Each condition is assigned a score of 1, 2, 3 or 6, depending on the mortality; scores are then summed into three classifying groups.
Derangement of hemodynamic and physiological admission parameters may be utilized to derive an acute illness severity score that predicts clinical outcomes. 15, 16 From modelling laboratory data collected at time of hospital admission we developed a predictive algorithm based on serum sodium, potassium, urea, albumin, red cell distribution width and white blood cell count. The underlying principle is that deviation beyond the boundaries of 'normal homeostasis' is an estimate of risk, although the relationship is non-linear and differs for each variable.
With any outcome predictor, found to be significant when tested as a univariate factor, they were then entered in the relevant multi-variable model.
Hospital costings
The Republic of Ireland proposes to introduce a 'Money follows the patient' system, a case-based funding model with DRG's, comparing hospital costs, quality and efficiency. The calculation of costs per case is adjusted by reference to the relative cost weight of each DRG and encompasses all costs appropriately associated with the delivery of that care including: (i) pay costs; (ii) non-pay costs-such as drugs, blood, medical and surgical supplies, radiology, laboratory equipment and supplies, heat, light and power; and (iii) costs of diagnostics, medical services, theatres, laboratories, wards and overhead allocations as appropriate. The hospital uses a number of standard accounting costing methodologies. The predominant approaches used in this exercise were activitybased costing and absorption costing. 17, 18 Both methods are used in parallel to cost individual patient episodes of care by directly linking cost to patient clinical data (e.g. laboratory and radiology tests, inpatient beds day). The accuracy of the costing is greatly enhanced because the hospital has utilized a robust devolved accounting and budgetary framework since 2004. The financial data are validated by externally audited annual financial statements; in addition strong relationships between costing and clinical risk profile/outcomes data suggest that the financial calculations provide a realistic view of the costs of care provision.
Statistical methods
Descriptive statistics were calculated for background demographic data, including means/standard deviations (SD), medians/IQR, or percentages. Comparisons between categorical variables and mortality were made using chi-square tests. We used a stepwise multi-variable logistic regression model to predict 30-day in-hospital death, adjusting risk estimates for major predictor variables. We used margins to estimate and interpret adjusted predictions for sub-groups, while controlling for other variables, using computations of average marginal effects. 19 Analysis of predictor variables for hospital LOS used truncated Poisson regression. 20 This dependent variable as for hospital total cost is positive integer; they cannot have zero values. We used robust standard errors for the parameter estimates, as recommended by Cameron and Trivedi. 20 The Poisson regression coefficients are the log of the rate ratio: the rate at which events occur is called the incidence rate. Thus, with the truncated Poisson regression model, we can interpret the coefficients in terms of incidence rate ratios (IRR).
Adjusted odds ratios (OR) and 95% confidence intervals (CI) or IRRs were calculated for those predictors that significantly entered the model (P < 0.10). Post-estimation methods including calculating the Area Under the Receiver Operator Curve (AUROC-logistic model) and estimating model fit from the Hosmer-Lemeshow goodness of fit (logistic GEE model). Statistical significance at P < 0.05 was assumed throughout. Stata v.13.1 (Stata Corporation, College Station, TX) statistical software was used for analysis. Patients with chronic disabling disease ( Table  2 -no disability vs. at least one code) were more likely to be female, were older, with a higher acute illness severity, Charlson co-morbidity index and more blood cultures for suspected sepsis. They had a longer in-hospital stay (7.5 (SD 6.6) vs. 3.5 (SD 4.8) days, P < 0.001) and a higher 30-day in-hospital mortality (5.2% vs. 0.8%, P < 0.001). Over three time periods of analysis, comparing 2002-05, 2006-09 and 2010-13, there was a significant trend for an increase in disabling disease and more elderly patients in emergency admissions; the mortality fell over time without change in the length of hospital stay (Table 3) .
Results
Patient demographics
Outcomes related to disabling disease and age-logistic model and zero-truncated Poisson models for outcomes of a 30-day in-hospital death or LOS, respectively
The major predictors of a 30-day in-hospital death were acute illness severity, 15, 16 Charlson co-morbidity index 14 and chronic disease score indicator 1, 4 in those patients with multiple disabling conditions (Figures 1 and 2 ; Tables 4 and 5 ). The full model to predict a death in-hospital by Day 30 had an AUROC of 0.85 (95% CI: 0.85, 0.86). Acute illness severity was the most significant mortality predictor (Table 4) , in the multi-variate model, as evident from the relative magnitude of the odds ratios of the respective predictors. However from analysis of variance (ANOVA), age (F = 129: P < 0.001) and disabling disease (F = 94: P < 0.001) were both independently predictive of a death by Day 30, with significant interactions between these predictors (F = 4.8: P < 0.001). Margins analyses, where predictions by chronic disabling disease were adjusted for other variables, using computations of average marginal effects post the multi-variable logistic regression model 19 demonstrated that chronic disabling disease was independently predictive in patients with 4+ disabling conditions, OR 1.70 (95% CI: 1.23, 2.35). The 30-day in-hospital mortality tended to increase with age, at any given disabling disease score (Figure 1) , substantially increasing in patients over the age of 85+, with an OR 1.63 (95% CI: 1.27, 2.10).
The major independent predictors of hospital LOS (Table 5) were acute illness severity, Charlson co-morbidity and chronic disease score. The full model to predict an LOS, above or below the median, had an AUROC of 0.69 (95% CI: 0.69, 0.70). From ANOVA, age (F = 92: P < 0.001) and chronic disabling disease (F = 563: P < 0.001) were both predictive of hospital LOS, with significant interaction (F = 3.1: P < 0.001). However, margins analyses showed that chronic disabling disease and age were strongly correlated; there was no specific contribution risk of a longer hospital stay conferred by age over and above that conferred by chronic disabling disease status (Figure 2 ; Table 5 ).
That is to say, it was the presence of chronic disabling disease or acute illness severity in the elderly that determined the LOS, rather than the patient age. The LOS increased proportionate to the chronic disabling disease score in a linear model (Figure 2 ). The multi-variate model estimated the risk profile of each group, based on the above parameters. The AUROC to predict an in-hospital death within 30 days was 0.85 (95% CI: 0.85, 0.86). 
Hospital total cost predictors-truncated Poisson model
The model was further tested by employing a truncated Poisson regression model on hospital total cost (data available for 5 years, 2008-12), including some categorical variables (e.g. disabling score groups) in the model as a series of indicator variables (Table 4 ; Figure 3 ). The data are truncated because there are no observations on individuals who stayed for zero days; the predictor variables were therefore regressed against LOS using the zero-truncated Poisson model. 20 The major predictors of hospital total costs were acute illness severity, Charlson co-morbidity indexes and chronic disease score. The full model to predict an LOS, above or below the median, had an AUROC of 0.76 (95% CI: 0.76, 0.77). From ANOVA, age (F = 16.7: P < 0.001) and chronic disabling disease (F = 27.7: P < 0.001) were both predictive of a death by Day 30, without significant interaction (F = 1.01: P = NS). However, margins analyses ( Figure 3) showed that chronic disabling disease and age were strongly correlated; there was little additional cost conferred by age over and above that conferred by chronic disabling disease status. It should be noted that chronic disease scores !2 points implied high episode costs; the model suggesting that costs increase non-linearly with disproportionate costs for those with chronic disease scores !2 points. The costs, related to the disabling scores of 0, 1, 2, 3 and 4+ points, were 4871E (95% CI: 2501, 7241), 7668E (95% CI: 6542, 8794), 10 072E (95% CI: 9257, 10 888), For LOS, we employed a zero-truncated Poisson regression model. 20 We used robust standard errors for the parameter estimates. 19 The Poisson regression coefficients are the log of the rate ratio: the rate at which events occur is called the incidence rate. Thus with the truncated Poisson regression model, we can interpret the coefficients in terms of IRR. Zero-truncated Poisson model to predict hospital total costs (E) as a function of disabling disease score, adjusted for age, illness severity and Charlson comorbidity index. The disabling disease score and age are strongly correlated; however total hospital costs are mainly attributable to the former. Chronic disease scores !2 points incurred particularly high costs.
12 198E (95% CI: 11 301, 13 086) and 15 875E (95% CI: 14 386, 17 363), respectively.
Discussion
This investigation revealed a rising trend in chronic disabling disease incidence among our emergency medical admissions. Although the inpatient age profile increased over the 12-year study period, particularly in the 40-60 and 85+ ranges, there was a relative risk reduction in mortality owing to improved care delivery through the establishment of an AMAU. 8, 9 The data is consistent with reported trends of increased life expectancy, attributable to improvements in living standards and healthcare, albeit with those extra lived years associating with an increased prevalence of chronic disabling conditions. Thus, although people may be living longer, quality of life in later years cannot be assumed.
1,3
The 30-day mortality model proved highly predictive of an in-hospital death, with acute illness severity, chronic disabling disease score (number of chronic disabling conditions in different systems) and age identified as independent predictors. As expected, there was a strong correlation between age and the occurrence of chronic disabling disease; however, the contribution of disabling disease as an LOS predictor outweighed that of age. This was further evidenced in the full cost model (AUROC of 0.76) with chronic disabling disease score again proving a major predictor while patient age contributing little to the cost prediction above that conferred by chronic disabling disease count. Although it is well established that older patients associate with chronic conditions, 21, 22 it would appear from our data that it is the chronic disabling disease score rather than patient age that principally drives acute medical patient costs. Numerous studies to date have examined the influence of chronic disease status on healthcare costs; 23, 24 however, their focus has been on specific chronic disabling diseases, 23 the primary care setting 22, 24 and overarching inpatient cost predictions. 25 Accordingly, to address the dearth of literature on acute medical costs as associated with disabling conditions, this is the first study of its kind offering novel insight into resource demand, found to be significantly driven by disabling condition status.
Of late, the burden of chronic disease has come under increased scrutiny; studies estimate 89% of all worldwide diseases to be chronic conditions by 2030, 26 and project one-quarter of the US population to live with multimorbidities by 2020. 25 In this context, inpatient disability incidence at our centre looks set to rise further in an already disablingdisease dominated patient cohort, wherein multiple-disabilities (disabling disease score !2 points) incur disproportionately higher episode costs. The ramifications for frontline hospital services are considerable and, consequently, there is a clear need for examining healthcare provision services to determine more effective disability management. Recommendations for addressing this issue have included the movement of significant proportions of disease management into the community, in turn allowing for the focus of hospital services on complex cases. 23, 27 Further, an increased emphasis has been placed on self-management 28, 29 and public health promotion programmes, encouraging behavioural change towards reducing disease risks factors 30 ; whenever possible, prevention of disease before it is established is the better solution. 7 As with any study, ours possesses both strengths and limitations. One such strength lies in the comprehensive nature of the data, which encompasses 66 933 individual hospital episodes over a 12-year period, reflecting real world clinical practice by capturing the most acute medically unwell in addition to those more stable patients. Further, the employed disabling disease score can be applied routinely, providing a simple metric for identifying those 'most at risk' and higher cost patients. The hospital has a number of other admitting services, most notably cardiology under which acute coronary syndromes are admitted, which limits the generalizability of the results. In addition, although the disabling disease score proves useful given its association with cost and LOS, the score itself does not quantify disease severity.
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